Slit Skin Smear (4 Site)

Function

The Slit Skin Smear (SSS) is a specialized diagnostic test used primarily for the detection and quantification of Mycobacterium leprae, the causative agent of Leprosy (Hansen’s Disease). Unlike a standard biopsy, this test involves making small, shallow incisions at specific sites to collect tissue fluid and cells from the dermis, which are then stained and examined under a microscope.

Why it is Ordered

It is ordered when a patient presents with skin lesions showing loss of sensation, thickened nerves, or nodules suspicious of leprosy. The '4-site' protocol usually includes both earlobes and two active skin lesions (or the elbows/knees) to increase the diagnostic yield. It helps in:

• Classification: Differentiating between Paucibacillary (PB) and Multibacillary (MB) leprosy.
• Treatment Monitoring: Assessing the response to Multi-Drug Therapy (MDT).
• Relapse Detection: Determining if a treated patient has active bacteria again.

Associated Conditions

• Tuberculoid Leprosy: Low bacterial load, often negative smears.
• Lepromatous Leprosy: High bacterial load, strongly positive smears.
• Atypical Mycobacterial Infections: Occasionally can cause confusion, though clinical presentation differs.

Interpretation

Results are reported using the Bacterial Index (BI), a logarithmic scale ranging from 0 to 6+. A BI of 0 means no bacilli were found in 100 oil-immersion fields. A high BI (e.g., 4+ to 6+) indicates a high bacterial load. The Morphological Index (MI) may also be reported, which measures the percentage of solid-staining (viable) bacilli versus fragmented (dead) ones, helping to gauge the effectiveness of ongoing treatment.